Yield Theory

Stock research

Kimberly-Clark Corporation KMB

Kimberly-Clark makes tissue and personal-care products including Huggies, Kleenex, and Kotex.
Loading delayed market data…

Delayed Cboe One market data via TradingView. It may differ from primary-exchange or consolidated quotes.

Ticker
KMB
Exchange
NASDAQ
Sector
Consumer
Founded

What moves KMB

Kimberly-Clark Corporation sits in Consumer Staples. Food, beverages, household goods, and tobacco — the classic defensive sector where pricing power meets inelastic demand. The forces that matter most for the sector — and therefore for KMB — are:

  • Input-cost inflation and pricing power
  • Private-label competition and volume trends
  • Currency, given large international revenue
  • Defensive rotation when growth slows

Congressional trading in KMB

No matched KMB transaction appears in the current verified House Clerk snapshot. We do not turn a missing row into a claim that no member has ever traded the security.

Congressional disclosures are delayed, range-based records—not real-time signals or proof of motive. See the source-linked tracker for scope and limitations.

The profile is free

KMB research stays free. Membership is the living thesis: what we believe, what we’re watching, and when conviction should end.

Get this month’s call for $15

Profiles related to Consumer Staples

How Yield Theory covers KMB

KMB intersects several of the themes in every Yield Theory issue. We don't chase headlines on individual tickers — we track where capital is rotating and explain what it means for the names in its path.

US marketsInternational markets

KMB — frequently asked questions

What sector is KMB in?

Kimberly-Clark Corporation is classified in the Consumer Staples sector and trades on the NASDAQ.

Do members of Congress trade KMB?

The current verified House Clerk snapshot contains no matched KMB transaction rows. That is not proof that no lawmaker has ever traded the security.

Is KMB a good investment?

We don't publish one-line buy/sell ratings. Yield Theory members get the full macro thesis, catalysts, and risks behind every name we cover, so you can decide with conviction. This page is research, not investment advice.

This page is independent research and educational information, not investment advice or a recommendation to buy or sell any security. Company facts are compiled from public sources. Do your own research.

See whether the KMB thesis still holds.

This page is company context and filings. Members get one sourced monthly call, a weekly evidence check, and the breakpoint written in advance. $15/month or $150/year.

$15/mo or $150/yr · cancel future renewals anytime · sources included